January 18, 2018
Apply for the second call for proposals for the funding scheme BRIDGE Discovery launched by the Commission for Technology and Innovation (CTI) and the SNSF.
For more information, please click here.
News
New InnoTREK grant awarded to Daniel Blessing
December 15, 2017
In response to the 2017 autumn call InnoTREK Mr. Daniel Blessing (right) submitted an innovative project on the development of cardiac-specific vectors. Hosted in the experimental cardiology department at the University Hospital of Lausanne of Professor Thierry Pedrazzini (left), the financial support of the InnoTREK grant allows the laureate to mature this technology towards a start-up project over the coming year. The vectors to be developed are intended to reinforce a therapeutic approach developed by Thierry Pedrazzini (left) and Samir Ounzain (center) to treat cardiac diseases with long non-coding RNAs.
Together they will drive forward their project “HaYa Therapeutics”, an innovative technology that consists in the development and testing of a first-in-class biopharmaceutical therapy to treat heart failure and that was recently distinguished as one of the Gold Winners of the MassChallenge 2017 Switzerland.
The InnoTREK grant, organized by the PACTT with the support of the FIT as part of the InnoPACTT fund, supports selected researchers of UNIL and CHUV who have the ambition to venture into the business world with their innovative projects. These successful projects are chosen in a competitive process from applications received during the two calls per year. Since the launch in 2013, 13 laureates of UNIL and CHUV have benefited from the InnoTREK grant.
Useful links :
PACTT congratulates CHUV MassChallenge laureates HaYa and Lymphatica
December 1, 2017
We are proud to announce that HaYa and Lymphatica, two start-up projects from the University Hospital of Lausanne (CHUV), are amongst the gold winners of the MassChallenge Switzerland.
HaYa Therapeutics is developing a first-in-class biopharmaceutical therapy to treat heart failure. The project is the result of a strong and dynamic collaboration between Thierry Pedrazzini (right), Samir Ounzain (center) and Daniel Blessing (left).
Lymphatica Medtech SA, founded by Marco Pisano (right) and Valentina Triacca (center), is developing a micropump-based medical device for treatment of lymphedema, a chronic, disabling side effect of anti-cancer therapies. Marco Pisano was supported by the spring 2016 InnoTREK grant.
PACTT wishes full success to both teams!
Useful links :
A first patient with primary liver cancer has been treated with a technology invented at the CHUV and licensed to Biocompatibles by the PACTT
November 16, 2017
In August 2015, PACTT was pleased to announce the signature of a license agreement and a development collaboration between CHUV and Biocompatibles International plc, part of the specialist healthcare company BTG plc, for a technology developed by Professor Alban Denys at the Radiodiagnostic and Interventional Radiology Unit at the CHUV. The technology enables the treatment of liver cancer using X-ray imageable microscopic beads loaded with a targeted anti-cancer drug placed directly in the liver
The UCL Cancer Institute and BTG plc have now begun to enroll patients into the first clinical trial. For Professor Denys “it is a great satisfaction to see this technology now entering the clinical stage, providing patients with liver cancer hope for additional treatment options.”
Tor read the complete presse relase, please click here.
For BTG website, please click here.
“Meet the FIT” au Biopôle à Epalinges, mercredi 15 novembre 2017 à 17h
October 26, 2017
La FIT, Fondation pour l’innovation technologique, peut vous aider à financer votre start-up.
Venez suivre la conférence « Meet the FIT » au Biopôle à Epalinges le mercredi 15 novembre 2017 à 17h.
Au programme, présentation du Biopôle, d’Innovaud et de la FIT.
Quelques liens utiles :
Business Ideas – dans la peau d’un entrepreneur
October 17, 2017
Venez découvrir des personnalités de l’entrepreneuriat et laissez-vous inspirer par leur success story.
La rencontre se déroulera le jeudi 9 novembre de 12h à 14h à l’UNIL, Amphimax 410.
Pour de plus amples informations et inscriptions, merci de cliquer ici.
La FIT, Fondation pour l’innovation technologique, peut vous aider à financer votre start-up.
September 25, 2017
Venez suivre la conférence « Meet the FIT » au Biopôle à Epalinges le mercredi 15 novembre 2017 à 17h.
Au programme, présentation du Biopôle, d’Innovaud et de la FIT.
Quelques liens utiles :
InnoPACTT: a financial support to create your start-up
September 11, 2017
|
Autumn CALL 2017 You are a UNIL-CHUV scientist and would like to create a start-up and need a financial support to start
|
 |
The AgroSustain project wins the first phase of Venture Kick
September 1, 2017
The AgroSustain project, supported by an Innotrek grant from the PACTT, has just won the first phase of Venture Kick. Thus, it obtains an amount of CHF 10’000.- allowing it to further progress on its lead compound : an organic fungicide to control a widespread and destructive grey mold disease “AgroSustain”.
Consequently, the project developed by Mrs Olga Dubey will be able to apply for the second phase of Venture Kick with a CHF 20’000.- grant. In the meantime, Mrs Dubey continues the development and testing of her novel experimental screening assay for the identification of organic pesticides coupled to state-of-the-art computational methods
Useful links :
WE HAVE MOVED!
August 31, 2017
